Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients

ABSTRACT This guideline provides an approach to the prevention and treatment of anticipatory chemotherapy‐induced nausea and vomiting (CINV) in children. It was developed by an international, inter‐professional panel using AGREE II methods and is based on systematic literature reviews. Evidence‐base...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric blood & cancer 2014-08, Vol.61 (8), p.1506-1512
Main Authors: Dupuis, L. Lee, Robinson, Paula D., Boodhan, Sabrina, Holdsworth, Mark, Portwine, Carol, Gibson, Paul, Phillips, Robert, Maan, Cathy, Stefin, Nancy, Sung, Lillian
Format: Article
Language:English
Subjects:
Adolescent
antineoplastic agents
Antineoplastic Agents - adverse effects
Antineoplastic Agents - therapeutic use
Child
Child, Preschool
Evidence-Based Medicine
Female
Hematology
Humans
Infant
Male
nausea
Nausea - chemically induced
Nausea - prevention & control
Neoplasms - drug therapy
Oncology
Pediatrics
supportive care
vomiting
Vomiting - chemically induced
Vomiting - prevention & control
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT This guideline provides an approach to the prevention and treatment of anticipatory chemotherapy‐induced nausea and vomiting (CINV) in children. It was developed by an international, inter‐professional panel using AGREE II methods and is based on systematic literature reviews. Evidence‐based recommendations for pharmacological and non‐pharmacological interventions to prevent and treat anticipatory CINV in children receiving antineoplastic agents are provided. Gaps in the evidence used to support the recommendations are identified. The contribution of this guideline to anticipatory CINV control in children requires prospective evaluation. Pediatr Blood Cancer 2014; 61:1506–1512. © 2014 Wiley Periodicals, Inc.
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.25063